Using Current Evidence in Selecting Antiepileptic Drugs for Use during Pregnancy
- 4 March 2005
- journal article
- Published by SAGE Publications in Epilepsy Currents
- Vol. 5 (2), 45-51
- https://doi.org/10.1111/j.1535-7597.2005.05201.x
Abstract
Children born to mothers taking antiepileptic drugs (AEDs) are at increased risk for findings of fetal anticonvulsant syndrome. Accepted treatment paradigms to minimize fetal risks include use of AED monotherapy and folic acid supplementation. However, as data are acquired from several ongoing pregnancy registries, differential risks among the various AED monotherapy regimens are being defined, further improving fetal outcomes.Keywords
This publication has 62 references indexed in Scilit:
- Australian Pregnancy Registry of Women Taking Antiepileptic DrugsEpilepsia, 2004
- EURAP: An International Registry of Antiepileptic Drugs and PregnancyEpilepsia, 2004
- Malformation Rates in Children of Women with Untreated EpilepsyDrug Safety, 2004
- Epilepsy and pregnancy: lamotrigine as main drug usedActa Neurologica Scandinavica, 2003
- The teratogenicity of anticonvulsant drugs: a progress reportJournal of Medical Genetics, 2002
- The Teratogenicity of Anticonvulsant DrugsNew England Journal of Medicine, 2001
- Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy.Archives of Disease in Childhood, 1996
- Improved pregnancy outcome in epileptic women in the last decade: Relationship to maternal anticonvulsant therapyBrain & Development, 1992
- The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of ageNeurotoxicology and Teratology, 1992
- Teratogenicity of Antiepileptic Drugs: Analysis of Possible Risk FactorsEpilepsia, 1988